Curiteva Launches Inspire Posterior Interbody Solutions

Curiteva, Inc., a leading technology and manufacturing company, has announced the commercial launch of its FDA-cleared Inspire Posterior Interbody Fusion Solutions. These are designed to enhance patient outcomes in transforaminal lumbar procedures. The 3D Printed Trabecular PEEK with HAFUSE Technology features an optimized porous structure that promotes bone ingrowth.

Dr. Kevin Foley, Chairman of Semmes-Murphey Neurologic and Spine Institute, highlighted the importance of maximizing bone ingrowth for successful fusion, noting the technology's superior biomechanical properties.

The Inspire platform, available in various sizes, uses Evonik VESTAKEEP® i4 3DF PEEK polymer and is manufactured on Curiteva's proprietary 3D printer. Mark Mohlman, Curiteva's EVP, emphasized their commitment to integrating Inspire technology across all implant solutions.

Eric Linder, Curiteva's CTO, remarked on the significance of the Inspire TLIF System launch, calling it a crucial industry milestone. The technology will be featured at the State of Spine Surgery Think Tank in San Jose del Cabo, Mexico, this week.